Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference10 articles.
1. Moyer, V. A. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 373–378 (2012).
2. Pi-Sunyer, X. et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N. Engl. J. Med. 373, 11–22 (2015).
3. Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).
4. Kim, D. D. et al. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial. Diabetes Obes. Metab. 17, 566–572 (2015).
5. Zafgen. Zafgen announces partial clinical hold affecting beloranib trials.
[online]
, (2015).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献